Skip to main content

Peer Review reports

From: The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study

Original Submission
27 Apr 2024 Submitted Original manuscript
1 May 2024 Author responded Author comments - Abel Gedefaw
28 May 2024 Reviewed Reviewer Report - Awol Yemane
4 Jun 2024 Reviewed Reviewer Report
27 Jun 2024 Author responded Author comments - Abel Gedefaw
Resubmission - Version 2
1 May 2024 Submitted Manuscript version 2
28 Jun 2024 Author responded Author comments - Abel Gedefaw
Resubmission - Version 3
28 Jun 2024 Submitted Manuscript version 3
3 Aug 2024 Reviewed Reviewer Report - Awol Yemane
15 Aug 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
19 Aug 2024 Editorially accepted
2 Sep 2024 Article published 10.1186/s12879-024-09763-6

You can find further information about peer review here.

Back to article page